Works matching IS 1021335X AND DT 2025 AND VI 53 AND IP 2


Results: 15
    1
    2
    3
    4
    5
    6
    7
    8

    SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells.

    Published in:
    Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8857
    By:
    • Miyamoto, Tomohiro;
    • Fukase, Naomasa;
    • Kawamoto, Teruya;
    • Fujiwara, Shuichi;
    • Hara, Hitomi;
    • Sawada, Ryoko;
    • Nakamatsu, Yuta;
    • Mifune, Yutaka;
    • Kakutani, Kenichiro;
    • Hoshino, Yuichi;
    • Hayashi, Shinya;
    • Matsumoto, Tomoyuki;
    • Matsushita, Takehiko;
    • Koyanagi-Aoi, Michiyo;
    • Aoi, Takashi;
    • Takemori, Toshiyuki;
    • Yahiro, Shunsuke;
    • Kuroda, Ryosuke;
    • Akisue, Toshihiro
    Publication type:
    Article
    9
    10
    11

    Bcl‑xL‑specific BH3 mimetic A‑1331852 suppresses proliferation of fluorouracil‑resistant colorectal cancer cells by inducing apoptosis.

    Published in:
    Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8859
    By:
    • Kato, Akira;
    • Takahashi, Hiroki;
    • Asai, Hiroyuki;
    • Uehara, Shuhei;
    • Harata, Shinnosuke;
    • Fujii, Yoshiaki;
    • Watanabe, Kaori;
    • Yanagita, Takeshi;
    • Suzuki, Takuya;
    • Ushigome, Hajime;
    • Shiga, Kazuyoshi;
    • Yamakawa, Yushi;
    • Ogawa, Ryo;
    • Mitsui, Akira;
    • Matsuo, Yoichi;
    • Takiguchi, Shuji
    Publication type:
    Article
    12
    13
    14
    15